Topic starter
11/10/2026 6:56 pm
TL;DR: MDR buyers are shifting from accepting AI branding to demanding evidence that investigations are complete, well-supported, and meaningful, while Gartner expects AI and agentic processes to take a larger share of detection and response work, according to Airmdr. The market is moving toward measurable quality, transparency, and human accountability rather than behind-the-scenes automation claims.
Editorial analysis by NHI Mgmt Group, based on content published by Airmdr: “The MDR Bar Is Moving”.
Key questions
Q: How should security teams evaluate AI-augmented MDR services?
A: They should evaluate them on validated outcomes, not on how much activity the provider automates.
Q: Why does AI change the way MDR services are measured?
A: AI compresses the time advantage that once separated providers, so speed becomes less informative.
Q: What are the signs that an MDR service is too opaque to trust?
A: Warning signs include cases with little evidence, unexplained conclusions, unclear analyst involvement, and no way to see whether the service actually improved over time.
Practitioner guidance
- Demand case-level evidence trails Require MDR providers to show the evidence, context, and reasoning behind each investigation so your team can assess whether the conclusion is supportable.
- Test the human-AI handoff Ask exactly where automation ends, where human review begins, and which identity or high-risk cases always require analyst validation.
- Evaluate investigation quality, not just speed Score the provider on completeness, clarity, actionability, and whether the write-up supports a defensible response decision.
Bottom line: MDR buying criteria are shifting from AI claims and response speed toward evidence quality, explainability, and operational accountability.
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →
11/10/2026 6:57 pm
Investigation transparency is becoming the real MDR control plane: speed is table stakes, but evidence quality and traceable reasoning are what make a detection service governable. When AI handles more of the workflow, the customer needs to inspect the case, not simply receive it. The practical conclusion is that MDR buyers should treat case provenance as an operational control, not a reporting nice-to-have.
A question worth separating out:
Q: What should teams compare when choosing between MDR providers?
A: They should compare evidence transparency, investigation quality, human oversight, identity-related response depth, and the ability to show measurable service performance. The relevant comparison is not just one provider's AI claim versus another's, but whether the service can demonstrate better outcomes with less customer burden.
👉 Read our full editorial: MDR buyers now want evidence, not just AI claims